This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
The “Immuno Bill” accelerates the energy providers such as DaVita have to transform kidney care, a key element of which is helping address common barriers to transplantation.
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2021. For the quarter, diluted earnings per share from continuing operations was $2.09, an…
At DaVita, we believe in the phrase, “One for all.” It signals a commitment from each of us to a greater whole. Together, we have a responsibility to achieve a greater good: to leave behind a better world for future generations.
DaVita Inc. today announced its 2025 Environmental, Social and Governance (ESG) goals and released its new ESG reports, bolstering its commitment to corporate citizenship and helping create…
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, April 29, 2021, at 5:00 p.m. Eastern Time. The company plans…